VOGX

Vogenx Inc

16.72

Oct 13 • 3:23 PM ET -0.42 (-2.45%)

Healthcare Biotechnology USA Micro NASD

Index	-
Market Cap	248.38M
Enterprise Value	249.06M
Income	-
Sales	-
Book/sh	-0.12
Cash/sh	0.01
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Aug 12, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	1307.27
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.06
Current Ratio	0.06
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-0.15
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Sep 02
EPS/Sales Surpr.	0.00% -

Insider Own	35.75%
Insider Trans	0.00%
Inst Own	12.95%
Inst Trans	75.11%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-26.65%
SMA50	-34.57%
SMA200	-34.57%
Trades

Shs Outstand	14.86M
Shs Float	9.54M
Short Float	0.28%
Short Ratio	0.15
Short Interest	0.03M
52W High	38.41 -56.47%
52W Low	12.95 29.11%
Volatility	13.82% 14.40%
ATR (14)	3.10
RSI (14)	35.61
Beta	-
Rel Volume	0.53
Avg Volume	182.81K
Volume	89,001

Perf Week	2.01%
Perf Month	-48.43%
Perf Quarter	-
Perf Half Y	-
Perf YTD	28.62%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.50
Target Price	48.50
Prev Close	17.14
Price	16.72
Change %	-2.45%

Oct-09-26 08:00AM	Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer (ACCESSWIRE)
Sep-22-26 09:00AM	Vogenx Appoints Ken Toombs to Board of Directors (ACCESSWIRE) -9.93%
Aug-17-26 12:25PM	Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering (PR Newswire) +6.56%
Aug-13-26 04:35PM	Vogenx Announces Closing of Initial Public Offering (ACCESSWIRE) +8.38%

Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.

PresidentMr. James Green

CFOMr. Steven R. Delmar

Chief Scientific OfficerDr. William Wilkison Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VOGX

Vogenx Inc

Upgrade your Finviz experience